Capitol Connection

Subscribe to Capitol Connection

Get updates and share your views on recent developments in science and technology policy.

  • July 17, 2014

    The National Children’s Study (NCS), which aims to follow the health of 100,000 babies until they turn 21, is now on hold following an assessment by the Institute of Medicine (IOM) and National Research Council (NRC). The IOM/NRC report notes several flaws with the study’s design and oversight. In response, National Institutes of Health (NIH) Director Francis Collins decided to halt the NCS until possible fixes can be evaluated.

     »

  • July 8, 2014

    Researchers have long used scientific specimen collections as sources of data on an animal's environment, diet and its very DNA. However, a debate has emerged among biologists over the ethics of collecting specimens of rare species whose numbers are dwindling. Some biologists argue that specimen collection provides them with critical information about a species. In addition, their collection counts for a small number of species compared with those that die from other man-made threats, such as habitat destruction. »

  • July 1, 2014

    The National Institutes of Health (NIH) and National Science Foundation (NSF) are teaming up to help researchers commercialize new biomedical discoveries. Researchers who are part of the new I-Corps at NIH pilot program will participate in a nine-week boot camp where they will meet with business experts and potential customers. I-Corps at NIH is the newest outgrowth of the NSF’s Innovation Corps (I-Corps) private-public partnership program, which helps commercialize selected federally funded research projects. »

  • June 24, 2014

    If you’re a researcher who receives federal funding, you probably feel that you’re spending almost as much time dealing with administration as doing science. Last week, two subcommittees of the House Science Committee held a joint hearing to look into the problem. »

  • June 24, 2014

    According to data recently released by the Food and Drug Administration, women report more adverse drug reactions than do men. While this finding could be due to greater reporting of side effects by women, it also may have something to do with the longstanding bias against using female animals in preclinical medical research. »